Anthem Biosciences confirms no encumbrance on promoter shares in FY26
Anthem Biosciences confirmed via a regulatory filing that its promoter group, led by Ishaan Bhardwaj, did not encumber any shares during FY26. The disclosure, submitted to BSE and NSE under SEBI takeover regulations, listed eight promoter group members, including foreign nationals, and confirmed compliance with required transparency norms.

*this image is generated using AI for illustrative purposes only.
Anthem Biosciences has confirmed that its promoter group did not pledge or encumber any shares during the financial year ended March 31, 2026. This disclosure ensures that the shareholding structure remains free of liens or charges, which is critical for maintaining shareholder confidence and regulatory compliance. The declaration was submitted to BSE and NSE on April 10, 2026, by Ishaan Bhardwaj on behalf of the promoter and promoter group.
The filing was made pursuant to Regulation 31(4) and 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. These regulations require promoters to disclose any encumbrance over shares held directly or indirectly. The confirmation from the promoter group indicates that no such financial arrangements were established involving the company's equity during the specified period.
Promoter Group Details
The disclosure identified the members of the promoter group, including Ishaan Bhardwaj and seven other individuals. The list was provided as Annexure A to the regulatory filing. The group consists of both Indian residents and foreign nationals, with specific details regarding their Permanent Account Numbers (PAN) where applicable.
| Name of the Promoter and Promoter Group | PAN |
|---|---|
| Ishaan Bhardwaj | |
| Kashmira Nayar | |
| Madhavi Jayanti | |
| Ajay Bhardwaj | |
| Arti Bhardwaj | |
| Raman Nayar | Not Applicable (Foreign National) |
| Pramila Raman Nayar | Not Applicable (Foreign National) |
| Nischel Rye Nayar | Not Applicable (Foreign National) |
| Rahul Vyan Nayar | Not Applicable (Foreign National) |
The company requested that the exchanges place this information on record. A copy of the declaration was also forwarded to the Audit Committee of Anthem Biosciences Limited for its information and records.
Historical Stock Returns for Anthem Biosciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.47% | -1.45% | -2.73% | +16.59% | +2.96% | +2.96% |
How might the absence of share encumbrances influence Anthem Biosciences' ability to secure future financing for expansion?
What impact will this clean shareholding structure have on investor confidence and stock volatility in the upcoming quarter?
Could the promoter group's current financial stability signal potential strategic acquisitions or partnerships in the near future?






























